美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Gastar Exploration

0.0561

0.0000

成交量：- -

成交额：- -

市值：1,228.22万

市盈率：-0.13

高：0.0561

开：0.0561

低：0.0561

收：0.0561

数据加载中...

总览公司新闻资讯公告

广生堂(300436.SZ)：GST-HG131联合GST-HG141针对乙肝经治患者的临床试验申请获得受理

广生堂(300436.SZ)：乙肝治疗创新药GST-HG131联合GST-HG141的II期临床研究获得优化审评审批试点项目确认书

广生堂(300436.SZ)子公司GST-HG131联合GST-HG141的II期临床研究获优化审评审批试点项目确认书

【广生堂：乙肝治疗创新药II期临床研究获得优化审评审批试点项目确认书】广生堂(300436.SZ)公告称，公司创新药控股子公司福建广生中霖生物科技有限公司收到北京市药品监督管理局下发的《优化创新药临床试验审评审批试点项目确认书》，同意GST-HG131联合GST-HG141的II期临床研究纳入试点项目，将有效缩短临床审评审批周期。GST-HG131是乙肝口服表面抗原抑制剂，目前全球范围内尚无同类产品上市；GST-HG141是新型乙肝核心蛋白或核衣壳调节剂，属于全新机制的在研抗乙肝病毒的一类新药。两者联合方案旨在探索基于核苷（酸）类似物NUC基础治疗上，在慢性乙型肝炎患者中的安全性、耐受性、有效性。该联合方案涉及的单药项目均已立项研发八年。

印度烟草股下跌报道称印度可能提高烟草制品税

环球市场播报

李伟教授：新加坡长期经济活力从何而来？

长江商学院

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/GST/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GST","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GST\",,,,,undefined,":{"symbol":"GST","market":"US","secType":"STK","nameCN":"Gastar Exploration","latestPrice":0.0561,"timestamp":1536249826821,"preClose":0.0561,"halted":4,"volume":0,"delay":0,"floatShares":69350000,"shares":218933504,"eps":-0.421675,"marketStatus":"退市","change":0,"latestTime":"05-13 17:17:10 EDT","open":0.0561,"high":0.0561,"low":0.0561,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.421675,"tradingStatus":0,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1747180800000},"marketStatusCode":4,"symbolChange":{"newSymbol":"GSTC","executeDate":"2018-09-07"},"adr":0,"adrRate":0,"listingDate":1136437200000,"exchange":"AMEX","adjPreClose":0.0561,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GST\",,,,,undefined,":{"symbol":"GST","floatShares":69350000,"roa":"--","roe":"--","lyrEps":-0.313395,"shares":218933504,"dividePrice":0,"high":0.0561,"amplitude":0,"preClose":0.0561,"low":0.0561,"week52Low":0.0561,"pbRate":"-0.13","week52High":1.39,"institutionHeld":0.3263,"latestPrice":0.0561,"eps":-0.421675,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.421675,"open":0.0561},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GST\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520540785","title":"广生堂(300436.SZ)：GST-HG131联合GST-HG141针对乙肝经治患者的临床试验申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2520540785","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520540785?lang=zh_cn&edition=fundamental","pubTime":"2025-03-17 20:08","pubTimestamp":1742213297,"startTime":"0","endTime":"0","summary":"智通财经APP讯，广生堂(300436.SZ)发布公告，公司创新药控股子公司福建广生中霖生物科技有限公司(简称“广生中霖”)于近日收到国家药品监督管理局下发的关于乙肝治疗创新药GST-HG131联合GST-HG141的临床试验申请《受理通知书》，拟针对核苷(酸)类似物NUC经治乙肝患者，挑战临床治愈乙肝。前述II期临床研究已于日前被纳入优化创新药临床试验审评审批试点项目，将有效缩短本次临床试验申请的审评审批周期。本次GST-HG131联合GST-HG141的II期临床试验申请获得受理，尚需进一步获得批准后才可开展临床研究，能否获得批准开展临床存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1262987.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GST","03347","300436","BK1576","BK0239","BK1141","BK1583"],"gpt_icon":0},{"id":"2518221805","title":"广生堂(300436.SZ)：乙肝治疗创新药GST-HG131联合GST-HG141的II期临床研究获得优化审评审批试点项目确认书","url":"https://stock-news.laohu8.com/highlight/detail?id=2518221805","media":"格隆汇","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518221805?lang=zh_cn&edition=fundamental","pubTime":"2025-03-10 21:05","pubTimestamp":1741611951,"startTime":"0","endTime":"0","summary":"2025年3月10日，福建广生堂药业股份有限公司创新药控股子公司福建广生中霖生物科技有限公司收到北京市药品监督管理局下发的《优化创新药临床试验审评审批试点项目确认书》，同意GST-HG131联合GST-HG141的II期临床研究纳入试点项目，将有效缩短临床审评审批周期。2025年1月，GST-HG131已按照II期临床方案要求完成了计划例数全部的患者入组。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/10210548635518.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK1574","159992","06978","BK1161","300436","GST"],"gpt_icon":0},{"id":"2518231082","title":"广生堂(300436.SZ)子公司GST-HG131联合GST-HG141的II期临床研究获优化审评审批试点项目确认书","url":"https://stock-news.laohu8.com/highlight/detail?id=2518231082","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518231082?lang=zh_cn&edition=fundamental","pubTime":"2025-03-10 20:16","pubTimestamp":1741608983,"startTime":"0","endTime":"0","summary":"智通财经APP讯，广生堂 公告，2025 年3月10日，公司创新药控股子公司福建广生中霖生物科技有限公司收到北京市药品监督管理局下发的《优化创新药临床试验审评审批试点项目确认书》，同意GST-HG131联合GST-HG141 的II期临床研究纳入试点项目，将有效缩短临床审评审批周期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259995.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","300436","GST"],"gpt_icon":0},{"id":"2518622835","title":"【广生堂：乙肝治疗创新药II期临床研究获得优化审评审批试点项目确认书】广生堂(300436.SZ)公告称，公司创新药控股子公司福建广生中霖生物科技有限公司收到北京市药品监督管理局下发的《优化创新药临床试验审评审批试点项目确认书》，同意GST-HG131联合GST-HG141的II期临床研究纳入试点项目，将有效缩短临床审评审批周期。GST-HG131是乙肝口服表面抗原抑制剂，目前全球范围内尚无同类产品上市；GST-HG141是新型乙肝核心蛋白或核衣壳调节剂，属于全新机制的在研抗乙肝病毒的一类新药。两者联合方案旨在探索基于核苷（酸）类似物NUC基础治疗上，在慢性乙型肝炎患者中的安全性、耐受性、有效性。该联合方案涉及的单药项目均已立项研发八年。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518622835","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518622835?lang=zh_cn&edition=fundamental","pubTime":"2025-03-10 19:58","pubTimestamp":1741607924,"startTime":"0","endTime":"0","summary":"广生堂(300436.SZ)公告称，公司创新药控股子公司福建广生中霖生物科技有限公司收到北京市药品监督管理局下发的《优化创新药临床试验审评审批试点项目确认书》，同意GST-HG131联合GST-HG141的II期临床研究纳入试点项目，将有效缩短临床审评审批周期。GST-HG131是乙肝口服表面抗原抑制剂，目前全球范围内尚无同类产品上市；GST-HG141是新型乙肝核心蛋白或核衣壳调节剂，属于全新机制的在研抗乙肝病毒的一类新药。两者联合方案旨在探索基于核苷（酸）类似物NUC基础治疗上，在慢性乙型肝炎患者中的安全性、耐受性、有效性。该联合方案涉及的单药项目均已立项研发八年。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/10195848633983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300436","159992","03347","BK1574","GST","BK1583","BK1141","06978","BK1161","159837","BK0239","BK1576"],"gpt_icon":0},{"id":"2488959432","title":"印度烟草股下跌 报道称印度可能提高烟草制品税","url":"https://stock-news.laohu8.com/highlight/detail?id=2488959432","media":"环球市场播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488959432?lang=zh_cn&edition=fundamental","pubTime":"2024-12-03 12:44","pubTimestamp":1733201040,"startTime":"0","endTime":"0","summary":"印度卷烟制造商的股票下跌， CNBC-TV18报道称，印度正在考虑提高烟草制品税。报道援引未具名人士的话称，由商品和服务税（GST）委员会设立的部长小组提议对烟草产品征收35%的税，而目前的税率为28%。ITC股价一度下跌3%，为近两个月最大跌幅。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：王永生","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2024-12-03/doc-incyeers8497669.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["GST"],"gpt_icon":0},{"id":"2485758427","title":"李伟教授：新加坡长期经济活力从何而来？","url":"https://stock-news.laohu8.com/highlight/detail?id=2485758427","media":"长江商学院","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485758427?lang=zh_cn&edition=fundamental","pubTime":"2024-11-20 10:14","pubTimestamp":1732068840,"startTime":"0","endTime":"0","summary":"长江商学院&nbsp;2024年11月18日 19:26 上海《2024年世界竞争力年报》显示，新加坡居全球最具竞争力经济体之冠，且其在劳动力市场、态度与价值观、科技基础设施等方面的排名均高居全球首位。新加坡作为东南亚城市型国家，面积不足740平方公里，人口仅约590万，却凭借其独特的经济发展模式，在国际舞台上大放异彩，非一日之...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OKzagZTNTf-KdRl269NBVzmSLkTiw0zgfqs-G9yepcwP4AA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OKzagZTNTf-KdRl269NBVzmSLkTiw0zgfqs-G9yepcwP4AA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241120A02N0600","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241120A02N0600","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["GST","BK4213","PR"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GST\",params:#limit:5,,,undefined,":[{"date":"2018-09-07","symbol":"GST","newSymbol":"GSTC","type":"symbolChange","dateTimestamp":1536292800000},{"market":"US","date":"2018-08-09","symbol":"GST","fiscalQuarterEnding":"2018/06","expectedEps":-0.05,"name":null,"time":"盘后","type":"earning","dateTimestamp":1533787200000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2018-05-10","symbol":"GST","fiscalQuarterEnding":"2018/03","expectedEps":-0.04,"name":null,"time":"盘后","type":"earning","dateTimestamp":1525924800000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2018-03-15","symbol":"GST","fiscalQuarterEnding":"2017/12","expectedEps":-0.03,"name":null,"time":"盘后","type":"earning","dateTimestamp":1521086400000,"reportTimeType":"post","actualEps":-0.03},{"market":"US","date":"2017-11-08","symbol":"GST","fiscalQuarterEnding":"2017/09","expectedEps":-0.04,"name":null,"time":"盘后","type":"earning","dateTimestamp":1510117200000,"reportTimeType":"post","actualEps":-0.05}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GST\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GST\",market:\"US\",delay:false,,,undefined,":{}}}